Forgive me if the headline above sounds slightly exploitive. My intention is not to piggyback on a personal tragedy, but I did want to get your attention.
In the fourteen years I’ve worked in marijuana law reform, few events have struck me as so needlessly tragic as the federal government’s consistent and deliberate stifling of medical cannabis research. Nowhere is the Feds’ refusal to allow this science more overt and inhumane than as it pertains to the investigation of cannabinoids as anti-cancer agents, particularly in the treatment of gliomas.
As noted in today’s wire stories regarding Senator Edward Kennedy’s diagnosis, glioma is an aggressive form of cancer that affects an estimated 10,000 Americans annually. Standard treatments for the cancer include radiation and chemotherapy, though neither procedure has proven particularly effective — with the disease killing approximately half its victims within one year and all within three years.
But what if there was an alternative treatment for gliomas that could selectively target the cancer while leaving healthy cells in tact? And what if federal bureaucrats were aware of this treatment, but deliberately withheld this information from the public?
Full Story
